Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis

References

• Somes MP, Turner RM, Dwyer LJ, et al. Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: a systematic review and meta-analysis. Vaccine. 2018;36(23):3199–3207.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Influenza (Seasonal). Geneva (Switzerland): World Health Organization; 2018.
   Google Scholar
• Cassini A, Colzani E, Pini A, et al. Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013. Euro Surveill. 2018;23(16):17–00454.
   Google Scholar
• Cuadrado-Payán E, Montagud-Marrahi E, Torres-Elorza M, et al. SARS-CoV-2 and influenza virus co-infection. Lancet. 2020;395(10236):e84.
   PubMed Web of Science ®Google Scholar
• Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal Influenzaa. Clin Infect Dis. 2019;68(6):895–902.
   PubMed Web of Science ®Google Scholar
• Taieb V, Ikeoka H, Ma FF, et al. A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients. Curr Med Res Opin. 2019;35(8):1355–1364.
   PubMed Web of Science ®Google Scholar
• Taieb V, Ikeoka H, Wojciechowski P, et al. Efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors in the treatment of influenza virus infection in high-risk and uncomplicated patients – a Bayesian network meta-analysis. Curr Med Res Opin. 2020. DOI:https://doi.org/10.1080/03007995.2020.1839400
   Google Scholar
• Du Z, Nugent C, Galvani AP, et al. Modeling mitigation of influenza epidemics by baloxavir. Nat Commun. 2020;11(1):2750.
   PubMed Web of Science ®Google Scholar
• Flicoteaux R, Protopopescu C, Tibi A, et al. Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial. BMJ Open. 2017;7(7):e014546.
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare. Status of the use of antivirals for influenza in the 2018/2019 season. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2019.
   Google Scholar
• Lee PY, Matchar DB, Clements DA, et al. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med. 2002;137(4):225–231.
   PubMed Web of Science ®Google Scholar
• Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health-a checklist: a report of the ISPOR good research practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–413.
   PubMed Web of Science ®Google Scholar
• Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labor and Welfare. Ethical guidelines for medical and health research involving human subjects. Tokyo (Japan): Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labor and Welfare; 2014.
   Google Scholar
• The Japanese Association for Infectious Diseases. Guidelines for the use of anti-influenza drugs. Tokyo (Japan): The Japanese Association for Infectious Diseases; 2019.
   Google Scholar
• Center for Outcomes Research and Economic Evaluation for Health. Guideline for preparing cost-effectiveness evaluation to the Central Social Insurance Medical Council. Wako (Japan): Center for Outcomes Research and Economic Evaluation for Health; 2019.
   Google Scholar
• Ministry of Health, Labour and Welfare. Japanese basic survey on wage structure on 2019. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2020.
   Google Scholar
• Ministry of Health, Labour and Welfare. Japanese basic survey on wage structure on 2018 by prefectures. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2019.
   Google Scholar
• Mäkelä MJ, Backer V, Hedegaard M, et al. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107(10):1481–1490.
   PubMed Web of Science ®Google Scholar
• Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930–938.
   PubMed Web of Science ®Google Scholar
• Laube BL, Janssens HM, de Jongh FH, International Society for Aerosols in Medicine, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37(6):1308–1331.
   PubMed Web of Science ®Google Scholar
• Arakawa H, Hamasaki Y, Kohno Y, et al. Japanese guidelines for childhood asthma 2017. Allergol Int. 2017;66(2):190–204.
   PubMed Web of Science ®Google Scholar
• Smith LE, D'Antoni D, Jain V, et al. A systematic review of factors affecting intended and actual adherence with antiviral medication as treatment or prophylaxis in seasonal and pandemic flu. Influenza Other Respir Viruses. 2016;10(6):462–478.
   PubMed Web of Science ®Google Scholar
• Ushijima K, Higuchi S, Fujimura A. Survey of compliance with oseltamivir phosphate therapy in Japan. Am J Ther. 2009;16(1):8–10.
   PubMed Web of Science ®Google Scholar
• Ministry of Education, Culture, Sports, Science, and Technology. Enforcement of the School Health and Safety Act, Chapter 3. Tokyo (Japan): Ministry of Education, Culture, Sports, Science, and Technology; 2019.
   Google Scholar
• Ministry of Health, Labour and Welfare. Q&A on influenza, FY 2019. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2019.
   Google Scholar
• Mabuchi T, Hosomi K, Yokoyama S, et al. Polypharmacy in elderly patients in Japan: analysis of Japanese real-world databases. J Clin Pharm Ther. 2020;45(5):991–996.
   PubMed Web of Science ®Google Scholar
• Yoshii N, Tochino Y, Fujioka M, et al. The comparison of the efficacy of baloxavir and neuraminidase inhibitors for patients with influenza A in clinical practice. Intern Med. 2020;59(12):1509–1513.
   PubMed Web of Science ®Google Scholar
• Yoshino Y, Kitazawa T, Ota Y. Clinical efficacy of baloxavir marboxil in the treatment of seasonal influenza in adult patients: a prospective observational study. Int J Gen Med. 2020;13:735–741.
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare. National health insurance drug price list 2020 August (oral). Tokyo (Japan): Ministry of Health, Labour and Welfare; 2020.
   Google Scholar
• Ministry of Health, Labour and Welfare. National health insurance drug price list 2020 August (topical agent). Tokyo (Japan): Ministry of Health, Labour and Welfare; 2020.
   Google Scholar
• Ministry of Health, Labour and Welfare. The national health and nutrition survey in Japan, 2018. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2020.
   Google Scholar
• National Institute of Infectious Diseases; Division of Tuberculosis and Infectious Disease Control, Ministry of Health, Labour and Welfare. Influenza in this season (2019/2020 season). Tokyo (Japan): National Institute of Infectious Diseases; Division of Tuberculosis and Infectious Disease Control, Ministry of Health, Labour and Welfare; 2020.
   Google Scholar
• Zaraket H, Saito R. Japanese surveillance systems and treatment for influenza. Curr Treat Options Infect Dis. 2016;8(4):311–328.
   PubMedGoogle Scholar